ProKidney Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	84.39	60.65	490.25	20.56	4.58
Short-Term Investments	244.61	302.3	0	0	0
Cash & Cash Equivalents	329	362.95	490.25	20.56	4.58
Cash Growth	-29.05%	-25.97%	2284.73%	349.06%	-
Other Current Assets	11.16	11.2	14.47	6.71	1.01
Total Current Assets	340.16	374.15	504.72	27.27	5.59
Property, Plant & Equipment	47.61	46.41	13.06	12.6	10.47
Goodwill and Intangibles	0	0	0.21	0.43	0.64
Total Long-Term Assets	47.61	46.41	13.28	13.03	11.12
Total Assets	387.76	420.55	518	40.3	16.7
Accounts Payable	3.38	5.1	3.04	2.83	0.78
Current Debt	1.09	0.8	0.49	0.27	0.23
Other Current Liabilities	14.83	19.14	7.34	9.21	4.5
Total Current Liabilities	19.3	25.04	10.87	12.31	5.5
Long-Term Debt	4.86	3.61	1.91	1.07	1.33
Other Long-Term Liabilities	0.57	0.57	0.28	0	0
Total Long-Term Liabilities	5.43	4.18	2.18	1.07	1.33
Total Liabilities	24.73	29.22	13.06	13.38	6.84
Total Debt	5.95	4.41	2.4	1.33	1.56
Debt Growth	92.46%	83.95%	79.84%	-14.43%	-
Retained Earnings	-1,149.16	-1,139.66	-1,104.12	-161.51	-106.36
Comprehensive Income	-0.04	0.13	0	0	0
Shareholders' Equity	-1,096.06	-1,103.4	-1,096.62	26.92	9.86
Net Cash / Debt	323.05	358.54	487.85	19.22	3.02
Net Cash / Debt Growth	-29.86%	-26.51%	2437.73%	536.77%	-
Net Cash Per Share	5.30	5.81	7.93	0.13	0.03
Working Capital	320.86	349.11	493.85	14.96	0.08
Book Value Per Share	-17.98	-17.88	-17.82	0.18	0.09

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).